Zolpidem Tartrate Sublingual Tablet
Product Images NDC 49884-898

16 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate Sublingual (NDC 49884-898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem (Zolpidem Tartrate 1)

Zolpidem (Zolpidem Tartrate 1)
Chemical structure diagram of Zolpidem tartrate, showing the molecular components of the active ingredient in the sublingual tablet formulation by Par Health USA, LLC.*
FDA Label Image

Zolpidem (Zolpidem Tartrate 2)

Zolpidem (Zolpidem Tartrate 2)
Illustration labeled Figure A showing a person sleeping in bed next to a nightstand with an alarm clock and a single pouch. The pouch is indicated by an arrow labeled "only 1 pouch," suggesting a usage or dosing instruction related to the product.*
FDA Label Image

Zolpidem (Zolpidem Tartrate 3)

Zolpidem (Zolpidem Tartrate 3)
A table labeled Figure B showing recommended dosing times for Zolpidem tartrate sublingual tablets. It lists wake-up times from 4 am to 9 am in the left column and corresponding latest times to take the tablet, from 12 midnight to 5 am, in the right column.*
FDA Label Image

Zolpidem (Zolpidem Tartrate 4)

Zolpidem (Zolpidem Tartrate 4)
Illustration from the Zolpidem tartrate sublingual tablet instructions showing how to find the latest dosing time. It depicts setting a wheel to the earliest time you must be awake by, and the corresponding latest time to take the tablet before, indicating the time must allow at least 4 hours of bedtime left.*
FDA Label Image

Zolpidem (Zolpidem Tartrate 5)

Zolpidem (Zolpidem Tartrate 5)
An instructional diagram labeled "Figure D" demonstrating how to open a pouch. Step 1 instructs to fold along the dotted line, and Step 2 directs to tear open at the notch located at the center of the folded dotted line.*
FDA Label Image

Zoplidem (Zolpidem Tartrate 6)

Zoplidem (Zolpidem Tartrate 6)
An instructional illustration labeled 'Figure E' showing hands opening a blister package, likely demonstrating how to remove a tablet from the packaging.*
FDA Label Image

Zolpidem (Zolpidem Tartrate 7)

Zolpidem (Zolpidem Tartrate 7)
An instructional line drawing labeled 'Figure F' showing an empty pouch placed on a tabletop near a clock. The image is likely intended to illustrate a step or concept related to the proper storage or handling of a medication pouch but includes no specific pharmaceutical branding or dosage details.*
FDA Label Image

Zolpidem (Zolpidem Tartrate 8)

Zolpidem (Zolpidem Tartrate 8)
An instructional illustration labeled 'Figure G' showing a close-up of a person's mouth with a sublingual tablet placed under the tongue by a hand. The image visually demonstrates the placement of a sublingual tablet for administration.*
FDA Label Image

1.5mg (Zolpidem Tartrate 9)

1.5mg (Zolpidem Tartrate 9)
Zolpidem tartrate sublingual tablet blister label showing 1.75 mg strength. The label indicates the tablet is human prescription drug by Par Health USA, LLC, with instructions to push the tablet through the blister from the other side. Barcode and manufacturing details are also visible.*
FDA Label Image

3.5mg (Zolpidem Tartrate 10)

3.5mg (Zolpidem Tartrate 10)
Zolpidem Tartrate Sublingual Tablet 3.5 mg blister pack label. The label shows the product strength and instructs to push the tablet through the blister from the other side. It includes manufacturing information for Par Health USA, made in India, and displays a barcode and controlled substance schedule IV symbol.*
FDA Label Image

1.75mg (Zolpidem Tartrate 11)

1.75mg (Zolpidem Tartrate 11)
Packaging label for Zolpidem tartrate Sublingual Tablet 1.75 mg, supplied as 30 unit-dose pouches with one sublingual tablet each. The label includes instructions for sublingual administration only, pharmacy dispensing guidance, storage conditions, and manufacturer details for Par Health USA, LLC. The label also features the drug schedule (C-IV) and a barcode.*
FDA Label Image

3.5mg (Zolpidem Tartrate 12)

3.5mg (Zolpidem Tartrate 12)
Packaging label for Zolpidem Tartrate Sublingual Tablet 3.5 mg by Par Health USA, LLC. The label indicates 30 unit-dose pouches, each containing one sublingual tablet. The label includes dosing and storage instructions, a barcode, and a pharmacist warning to dispense with a Medication Guide and Dosing Time Tool.*
FDA Label Image

1.75mg Front (Zolpidem Tartrate 13)

1.75mg Front (Zolpidem Tartrate 13)
Label for Zolpidem Tartrate Sublingual Tablet 1.75 mg, a prescription sublingual tablet. The label includes usage warnings, storage instructions, and manufacturing details by Par Health USA, Rochester, MI. It indicates the package contains 1 sublingual tablet and emphasizes sublingual administration only, with a barcode and NDC number 49884-898-52.*
FDA Label Image

1.75 mg Back (Zolpidem Tartrate 14)

1.75 mg Back (Zolpidem Tartrate 14)
Text panel for Zolpidem tartrate sublingual tablet provides adult dosage instructions and a dosing time chart. It includes guidance to open only one pouch when ready to use, find the latest safe dosing time based on wake-up time, and take the tablet only if at least 4 hours of bedtime remain. Instructions specify placing the tablet under the tongue until it disintegrates and note the tablet should not be swallowed whole.*
FDA Label Image

3.5 mg Front (Zolpidem Tartrate 15)

3.5 mg Front (Zolpidem Tartrate 15)
Label for Zolpidem Tartrate Sublingual Tablet 3.5 mg, a sublingual tablet for prescription use. The label includes dosage strength, administration instructions emphasizing sublingual use only, storage conditions, and manufacturer information for Par Health USA, LLC. The package contains 1 sublingual tablet and highlights the drug's schedule IV classification.*
FDA Label Image

3.5 mg Back (Zolpidem Tartrate 16)

3.5 mg Back (Zolpidem Tartrate 16)
Text panel providing dosing instructions for Zolpidem tartrate sublingual tablets. It advises taking one tablet per night as directed, includes a dosing time chart correlating wake time with latest intake time, and instructions to place the tablet under the tongue to disintegrate completely before swallowing. Also notes the importance of having at least 4 hours left in bedtime before taking the tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.